Tuberculosis Diagnostics Market Size, Share, Trends, Growth Outlook

Tuberculosis Diagnostics Market is estimated to increase at a growth rate of 6.2% CAGR over the forecast period from 2024 to 2030.

The global Tuberculosis Diagnostics Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Test (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance, Others), By End-user (Diagnostic Laboratories, Hospitals & Clinics, Others).

An introduction to Tuberculosis Diagnostics Market in 2024

Playing a crucial role in tuberculosis (TB) control and management, the Tuberculosis Diagnostics Market offers a range of diagnostic tests, assays, and technologies for the rapid and accurate detection of TB infection and disease. Tuberculosis diagnostics include sputum-based tests (such as smear microscopy, culture, and nucleic acid amplification tests), serological tests, molecular assays (such as GeneXpert MTB/RIF), and imaging modalities (such as chest X-rays and computed tomography scans) to identify TB infection, assess disease severity, and monitor treatment response. The market serves clinicians, laboratory professionals, and public health agencies involved in TB diagnosis and surveillance, offered by diagnostic companies, medical device manufacturers, and healthcare providers. With the persistent global burden of TB, the emergence of drug-resistant TB strains, and the need for early diagnosis and prompt treatment initiation, the Tuberculosis Diagnostics Market remains a critical component of TB control efforts. As researchers develop new diagnostic technologies, improve test accuracy, and expand access to TB testing in resource-limited settings, the market drives innovation in TB diagnostics, facilitating early case detection, reducing transmission, and ultimately, contributing to TB elimination goals worldwide.

Tuberculosis Diagnostics Market Trend: Adoption of Point-of-Care (POC) Testing Solutions

One prominent trend in the Tuberculosis Diagnostics market is the increasing adoption of point-of-care (POC) testing solutions for the rapid and accurate diagnosis of tuberculosis (TB). POC testing offers several advantages including quicker turnaround times, accessibility in remote or resource-limited settings, and the ability to initiate timely treatment interventions. With the global burden of TB remaining high, particularly in low- and middle-income countries, there is a growing emphasis on decentralized diagnostic approaches to improve case detection rates and reduce transmission. As a result, there has been a surge in the development and commercialization of POC TB diagnostic devices, such as molecular assays, rapid serological tests, and nucleic acid amplification tests (NAATs), driving market growth and innovation in TB diagnostics.

Tuberculosis Diagnostics Market Driver: Persistence of High TB Burden and the Threat of Drug-Resistant Strains

A significant driver in the Tuberculosis Diagnostics market is the persistence of high TB burden worldwide and the threat posed by drug-resistant strains of the bacterium Mycobacterium tuberculosis. Despite concerted global efforts to combat TB, the disease remains a major public health challenge, with millions of new cases and deaths reported annually. Furthermore, the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) strains poses additional challenges to TB control and treatment efforts. Timely and accurate diagnosis is crucial for effective TB management, including appropriate treatment initiation and infection control measures. The ongoing prevalence of TB and the threat of drug-resistant strains drive demand for robust and reliable TB diagnostic tools, fueling market growth and investment in TB diagnostics technologies.

Tuberculosis Diagnostics Market Opportunity: Expansion of Molecular Diagnostics and Point-of-Care Testing

An emerging opportunity in the Tuberculosis Diagnostics market lies in the expansion of molecular diagnostics and point-of-care testing solutions for TB diagnosis and monitoring. Molecular diagnostic techniques, such as polymerase chain reaction (PCR) assays and line probe assays, offer high sensitivity and specificity for the detection of TB bacteria and drug resistance markers. Additionally, advancements in POC testing technologies enable rapid, on-site TB diagnosis in settings with limited laboratory infrastructure or trained personnel. By expanding access to molecular diagnostics and POC testing solutions, particularly in high-burden regions and vulnerable populations, stakeholders can improve case detection rates, facilitate timely treatment initiation, and reduce the burden of TB globally. This expansion of molecular diagnostics and POC testing presents opportunities for market growth, innovation, and improved TB control efforts in the Tuberculosis Diagnostics market.

Tuberculosis Diagnostics Market Market Segmentation

By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Tuberculosis Diagnostics Market Companies

Abbott Laboratories
Becton, Dickinson and Company
Becton, Dickinson and Company
BioMérieux SA
Cepheid
F. Hoffmann-La Roche AG
Hain Lifescience GmbH
Hologic Inc
QIAGEN GmbH
Thermo Fisher Scientific Inc

Reasons to Buy the Tuberculosis Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Tuberculosis Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Tuberculosis Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Tuberculosis Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Tuberculosis Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Tuberculosis Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Tuberculosis Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Tuberculosis Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Tuberculosis Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Tuberculosis Diagnostics Industry
4.2 Key Market Trends in Tuberculosis Diagnostics Industry
4.3 Potential Opportunities in Tuberculosis Diagnostics Industry
4.4 Key Challenges in Tuberculosis Diagnostics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Tuberculosis Diagnostics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Tuberculosis Diagnostics Market Outlook by Segments
7.1 Tuberculosis Diagnostics Market Outlook by Segments, $ Million, 2021- 2030
By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

8 North America Tuberculosis Diagnostics Market Analysis and Outlook To 2030
8.1 Introduction to North America Tuberculosis Diagnostics Markets in 2024
8.2 North America Tuberculosis Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Tuberculosis Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

9 Europe Tuberculosis Diagnostics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Tuberculosis Diagnostics Markets in 2024
9.2 Europe Tuberculosis Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Tuberculosis Diagnostics Market Size Outlook by Segments, 2021-2030
By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

10 Asia Pacific Tuberculosis Diagnostics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Tuberculosis Diagnostics Markets in 2024
10.2 Asia Pacific Tuberculosis Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Tuberculosis Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

11 South America Tuberculosis Diagnostics Market Analysis and Outlook To 2030
11.1 Introduction to South America Tuberculosis Diagnostics Markets in 2024
11.2 South America Tuberculosis Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Tuberculosis Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

12 Middle East and Africa Tuberculosis Diagnostics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Tuberculosis Diagnostics Markets in 2024
12.2 Middle East and Africa Tuberculosis Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Tuberculosis Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Becton, Dickinson and Company
Becton, Dickinson and Company
BioMérieux SA
Cepheid
F. Hoffmann-La Roche AG
Hain Lifescience GmbH
Hologic Inc
QIAGEN GmbH
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Test
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others